We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read moreWe discuss gene therapy pricing and reimbursement, manufacturing methods, analytical analysis, and k...
Read moreOur experts reflect on the trends that shaped the European pricing and market access landscape in 20...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreIntroduction The European landscape has seen both approvals and withdrawals of cell and gene therapi...
Read moreWe look at whether payers are willing to pay for innovative gene therapies & CAR-Ts and the impact o...
Read moreOur Market Access Analysts discuss the proposed changes to CAR-T reimbursement in the US and conside...
Read moreFrance’s Health Innovation Plan 2030, announced by President Emmanuel Macron back in June 2021, wi...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read more